Vitamin B1 is also required for the breakdown of fats and protein
Weight loss resistance affects millions of adults whose bodies don't respond adequately to single-agent GLP-1 therapy alone
No UK Marketing Authorisation Identified No current UK marketing authorisation for a medicinal product containing 5-amino-1-methylquinolinium was identified in the official sources reviewed for this article
In contrast to findings with behavioral 20,21,22 and other pharmacological interventions 10,12,13 , the similar mean weight loss achieved with semaglutide 2.4 mg in STEP 5 at weeks 52 and 104 (15.6% and 15.2%, respectively) suggests that, on average, there is minimal weight regain over 104 weeks when once-weekly semaglutide therapy is continued
Therefore, you accumulate fat
Treatment should not be delayed if neurological symptoms occur, as nerve damage may become irreversible without prompt B12 replacement